Related Experiment Videos
Hyperekplexia phenotype due to compound heterozygosity for GLRA1 gene mutations
M N Vergouwe1, M A Tijssen, A C Peters
1Department of Human Genetics, Medical Genetics Center South-West Netherlands, Leiden.
Annals of Neurology
|October 8, 1999
Summary
Hyperekplexia, or startle disease, is a neurological disorder. This study found that compound heterozygous mutations in the GLRA1 gene cause hyperekplexia, while carrying only one mutation results in no clinical signs.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- Hyperekplexia, also known as startle disease, is a neurological disorder affecting newborns.
- It is characterized by neonatal generalized stiffness and exaggerated startle reflexes.
- Previous research linked hyperekplexia to the GLRA1 gene on chromosome 5q33-35, with both dominant and recessive inheritance patterns observed.
Observation:
- Genetic analysis was performed on a family with two affected children and healthy parents.
- Pedigree analysis initially suggested recessive inheritance.
- Haplotype construction indicated compound heterozygosity for GLRA1 mutations in affected children.
Findings:
- Two distinct missense mutations in the GLRA1 gene were identified in the affected siblings.
- These mutations alter specific amino acid residues (R252H and R392H).
- Individuals with compound heterozygous mutations exhibited hyperekplexia, while carriers of a single mutation were asymptomatic.
Implications:
- This study elucidates the genetic basis of hyperekplexia, highlighting the role of compound heterozygosity in GLRA1.
- It demonstrates that inheriting two different GLRA1 mutations is necessary to manifest the disease phenotype.
- Findings contribute to understanding genotype-phenotype correlations in neurological disorders and may inform diagnostic approaches.